Skip to content
The Nexus
DossierENTITY

Caralynn Matassa

Coverage of Caralynn Matassa in the Nexus archive.

Earliest in view: Aug 19 · 09:03 UTCMost recent: Aug 19 · 09:03 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHAug 19 · 09:03 UTCBUSINESS INSIDER
    Zepbound helped me lose 18% of my body weight. I wish I didn't feel the need to apologize for it.

    The author details her weight loss journey after starting Zepbound, a GLP-1 medication also known as tirzepatide. She lost 30 pounds, representing about 18% of her body weight, which greatly improved chronic pain in her feet and knees. Despite the success, she notes the social stigma and feeling that apologizing for improving one's health is strange.

Caralynn Matassa · Dossier · The Nexus